SIM
MRNA icon

Sentry Investment Management’s Moderna MRNA Stock Holding History

Sentry Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-924
Closed -$27K – 317
2025
Q4 		$27K Hold
924
– – 0.02% 484
2025
Q3 		$26K Sell
924
-176
-16% -$4.91K 0.02% 499
2025
Q2 		$36K Hold
1,100
– – 0.02% 441
2025
Q1 		$28K Buy
+1,100
New +$39K 0.02% 443
2024
Q4 		– Sell
-1,581
Closed -$106K – 480
2024
Q3 		$106K Hold
1,581
– – 0.04% 329
2024
Q2 		$188K Sell
1,581
-324
-17% -$41K 0.08% 208
2024
Q1 		$203K Buy
+1,905
New +$192K 0.08% 243
2023
Q4 		– Sell
-1,852
Closed -$191K – 504
2023
Q3 		$191K Sell
1,852
-328
-15% -$36.6K 0.09% 230
2023
Q2 		$265K Hold
2,180
– – 0.1% 212
2023
Q1 		$335K Sell
2,180
-61
-3% -$10.1K 0.14% 173
2022
Q4 		$403K Sell
2,241
-139
-6% -$22.7K 0.18% 142
2022
Q3 		$281K Hold
2,380
– – 0.13% 167
2022
Q2 		$340K Sell
2,380
-463
-16% -$66.2K 0.15% 142
2022
Q1 		$490K Sell
2,843
-502
-15% -$84.5K 0.16% 137
2021
Q4 		$850K Buy
3,345
+959
+40% +$280K 0.22% 112
2021
Q3 		$918K Buy
+2,386
New +$880K 0.27% 90

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sentry Investment Management's MRNA Position: Q1 2026 in Review

Sentry Investment Management sold out of Moderna (MRNA) in Q1 2026, closing a stake of 924 shares — an estimated $27K sold.

Sentry Investment Management first reported a position in MRNA in Q3 2021 and held it in 16 quarters. The position peaked at $918K in Q3 2021. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Sentry Investment Management reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 924 Moderna shares in Q1 2026, an estimated $27K.
  • Sentry Investment Management first reported a position in Moderna in Q3 2021 and held it in 16 quarters.
  • Sentry Investment Management's Moderna position peaked at $918K in Q3 2021.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.